Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Chen

Showing results (161-170 of 274) with videos related to

Pageof 28
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 2011
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activityLaura H Jacobson, S Renee Commerford, Sarah P Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosisKim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Chemistry & Biology|November 23, 2006
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation modelShifeng Pan, Yuan Mi, Charles Pally, et al.
Emerging Infectious Diseases|October 25, 2023
Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021-April 2023Alexandria B Boehm, Debra A Wadford, Bridgette Hughes, et al.
NPJ Parkinson'S Disease|November 7, 2025
Mapping the developmental path for Parkinson's disease therapeuticsNeel T Dhruv, Sarah Robinson Schwartz, Christine Swanson-Fischer, et al.
Molecular Neurodegeneration|October 11, 2024
Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's diseaseAnantharaman Shantaraman, Eric B Dammer, Obiadada Ugochukwu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 30, 2024
ADNI Biomarker Core: A review of progress since 2004 and future challengesLeslie M Shaw, Magdalena Korecka, Edward B Lee, et al.
Annals of Neurology|March 16, 2026
Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma BiomarkersChristopher A Brown, Katheryn A Q Cousins, Magdalena Korecka, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's DiseaseAnantharaman Shantaraman, Eric B Dammer, Obiadada Ugochukwu, et al.
Pageof 28

Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 28, 2011
Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activityLaura H Jacobson, S Renee Commerford, Sarah P Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosisKim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Chemistry & Biology|November 23, 2006
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation modelShifeng Pan, Yuan Mi, Charles Pally, et al.
Emerging Infectious Diseases|October 25, 2023
Trends of Enterovirus D68 Concentrations in Wastewater, California, USA, February 2021-April 2023Alexandria B Boehm, Debra A Wadford, Bridgette Hughes, et al.
NPJ Parkinson'S Disease|November 7, 2025
Mapping the developmental path for Parkinson's disease therapeuticsNeel T Dhruv, Sarah Robinson Schwartz, Christine Swanson-Fischer, et al.
Molecular Neurodegeneration|October 11, 2024
Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's diseaseAnantharaman Shantaraman, Eric B Dammer, Obiadada Ugochukwu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 30, 2024
ADNI Biomarker Core: A review of progress since 2004 and future challengesLeslie M Shaw, Magdalena Korecka, Edward B Lee, et al.
Annals of Neurology|March 16, 2026
Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma BiomarkersChristopher A Brown, Katheryn A Q Cousins, Magdalena Korecka, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's DiseaseAnantharaman Shantaraman, Eric B Dammer, Obiadada Ugochukwu, et al.
Pageof 28